MedTech World

Finger-Based Blood Pressure Tracking | Mark Khachaturian, Wellvii | MTW North America 2026

At MedTech World in Miami, Welvie CEO Mark Khachaturian unveiled a finger‑cuff blood‑pressure monitor designed to replace the century‑old arm cuff. The device captures arterial pressure from the fingertip, offering a painless, portable, rechargeable solution aimed at improving the roughly 35 % compliance rate in the United States. Khachaturian explained that the finger‑cuff provides clinically accurate readings without the daily calibration required by optical wrist devices. The algorithm received FDA clearance in 2024, with the hardware expected to be cleared next month. Medicare’s 2019 remote‑monitoring reimbursement of $1,500 per patient per year under CPT codes creates a clear financial incentive for both patients and providers. He highlighted a $125 consumer price, one‑million pre‑orders, and a goal to displace the 80 million arm cuffs sold globally. Integration uses Bluetooth and a cellular chip to stream data to a cloud‑based Azure platform, compliant with HIPAA and GDPR, and the company already runs pilots in the U.S., Asia and Europe. The launch could accelerate home‑based hypertension management, generate massive real‑world data for AI‑driven analytics, and lay the groundwork for a modular platform that adds EKG and other vitals. Global scaling and reimbursement alignment position Welvie to reshape remote patient monitoring and reduce cardiovascular risk at scale.